Global Transdermal Skin Patches Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Transdermal Skin Patches Market is presumed to reach the market size of nearly USD 13.3 Billion by 2032 from USD 8.41 Billion in 2023 with a CAGR of 5.23% under the study period 2024-2032.

A transdermal patch is a type of transdermal technology. It is a medicated adhesive patch placed on the skin to deliver a specific dose of medication. These patches provide medication dose though the skin using the diffusion technique, which later gets released in the bloodstream over a long period. These patches are effectively used for the treatment of hormonal and cardiac disorders. These patches are also used to treat migraine, Parkinsons disease, Alzheimer's, strokes, HIV, osteoporosis, dermatology-related issues, and restless leg syndrome treatments.

MARKET DYNAMICS

The primary factor contributing to the growth of the market is the increasing advantages of transdermal medicine over the conventional way of medications (medications for gastrointestinal toxicity), resulting in nausea and vomiting. As they are non-invasive in nature, they reduce the inconvenience caused due to intravenous or parenteral therapies. The main advantage is that the patch provides a controlled release of the medication into the patient, generally through either a porous membrane covering the storage of medication or through body heat melting thin layers of medication deposited in the adhesive. Additionally, increasing funding and investments for drug development boosts the market growth. However, the skin's inability to absorb a range of active substances is expected to impede the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Transdermal Skin Patches. The growth and trends of Transdermal Skin Patches industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Transdermal Skin Patches market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Reservoir
Drug-in-Adhesive (Single Layer, Multilayer)
Microneedle
Matrix
Others (Vapor, etc.)

By Application

Pain Management
Hormonal Disorders
Smoking Reduction and Cessation Aid
Neurological Disorders
Cardiovascular Disorders
Others (Motion Sickness, Overactive Bladder, etc.)

By Sales Type

Prescription
Over-the-Counter (OTC)

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Transdermal Skin Patches market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transdermal Skin Patches market include Hisamitsu Pharmaceutical Co. Inc., Viatris Inc., Nitto Denko Corporation, Novartis AG, Luye Pharma Group, Teikoku Pharma, Samyang Holdings Corporation, Gedeon Richter PLC, AdhexPharma, Sparsha Pharma International Pvt Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11213473

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. TRANSDERMAL SKIN PATCHES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Sales Type
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data
5.3. Analysis By Product Type
5.4. Reservoir Historic and Forecast Sales By Regions
5.5. Drug-in-Adhesive (Single Layer, Multilayer) Historic and Forecast Sales By Regions
5.6. Microneedle Historic and Forecast Sales By Regions
5.7. Matrix Historic and Forecast Sales By Regions
5.8. Others (Vapor, etc.) Historic and Forecast Sales By Regions

6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Pain Management Historic and Forecast Sales By Regions
6.5. Hormonal Disorders Historic and Forecast Sales By Regions
6.6. Smoking Reduction and Cessation Aid Historic and Forecast Sales By Regions
6.7. Neurological Disorders Historic and Forecast Sales By Regions
6.8. Cardiovascular Disorders Historic and Forecast Sales By Regions
6.9. Others (Motion Sickness, Overactive Bladder, etc.) Historic and Forecast Sales By Regions

7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY SALES TYPE

7.1. Overview By Sales Type
7.2. Historical and Forecast Data
7.3. Analysis By Sales Type
7.4. Prescription Historic and Forecast Sales By Regions
7.5. Over-the-Counter (OTC) Historic and Forecast Sales By Regions

8. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data
8.3. Analysis By Distribution Channel
8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
8.5. Retail Pharmacies Historic and Forecast Sales By Regions
8.6. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL TRANSDERMAL SKIN PATCHES MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE TRANSDERMAL SKIN PATCHES COMPANIES

10.1. Transdermal Skin Patches Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF TRANSDERMAL SKIN PATCHES INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Hisamitsu Pharmaceutical Co. Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Viatris Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Nitto Denko Corporation
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Novartis AG
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Luye Pharma Group
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Teikoku Pharma
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Samyang Holdings Corporation
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Gedeon Richter PLC
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. AdhexPharma
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Sparsha Pharma International Pvt Ltd
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies